Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ · Healthcare
Orchestra BioMed Holdings, Inc. EBITDA 2022–2025
Orchestra BioMed Holdings, Inc. annual/quarterly ebitda history and growth rate from 2022 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Orchestra BioMed Holdings, Inc. ebitda for the quarter ending March 31, 2026 was -22.0 M, a 16.71% increase year-over-year.
- Orchestra BioMed Holdings, Inc. ebitda for the twelve months ending March 31, 2026 was -66.6 M.
- Orchestra BioMed Holdings, Inc. annual ebitda for 2025 was -51.5 M, a 19.55% decrease from 2024.
- Orchestra BioMed Holdings, Inc. annual ebitda for 2024 was -64.0 M, a 24.94% increase from 2023.
- Orchestra BioMed Holdings, Inc. annual ebitda for 2023 was -51.2 M, a 57.91% increase from 2022.
- Orchestra BioMed Holdings, Inc. annual ebitda for 2022 was -32.4 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Orchestra BioMed Holdings, Inc. EBITDA — FAQ
Orchestra BioMed Holdings, Inc. (OBIO) ebitda over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see OBIO's ebitda history?
The chart and table above show Orchestra BioMed Holdings, Inc.'s ebitda by year and by quarter, including the growth rate.